A population-based study on the burden of hospitalized pediatric pneumococcal disease in Taiwan before and after the introduction of 13-valent pneumococcal conjugate vaccine into the childhood immunization program in 2015
Residual clinical and economic burden of pneumococcal diseases remained substantial after PCV13 inclusion into Taiwan's Childhood Immunization Program. To further reduce the disease burden among children, additional research to investigate the cause of increasing trends of hospitalized invasive pneumococcal disease, non-bacteremic pneumococcal pneumonia and acute otitis media in the post-PCV13 era will be required.
Authors
- Cindy Thiow Koon Lim (ORCID: https://orcid.org/0000-0001-7408-2422)
- Isaya Sukarom (ORCID: https://orcid.org/0000-0002-0568-8145)
- Ting‐An Yen (ORCID: https://orcid.org/0000-0002-2288-6784)
- Eriko Yamada
- Jhong-Lin Wu (ORCID: https://orcid.org/0000-0003-3564-7608)
- See‐Hwee Yeo (ORCID: https://orcid.org/0000-0001-8658-8172)
- Hung-Wei Lin
- Dony Patel (ORCID: https://orcid.org/0000-0002-9153-4176)
- Ling-Ya Huang
- Chi‐Chuan Wang (ORCID: https://orcid.org/0000-0002-4597-4859)
Institutions
- Mercy Medical Center (US)
- National Taiwan University (TW)
- IQVIA (United Kingdom) (GB)
- University of Phayao (TH)
- MSD K.K. (Japan) (JP)
- Eye & Retina Surgeons (SG)
- National Taiwan University Hospital (TW)
Publication Details
- Journal
- BMC Infectious Diseases
- Published
- 2025-02-05
- DOI
- https://doi.org/10.1186/s12879-024-10379-z
- Citations
- 2
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 2.71